デフォルト表紙
市場調査レポート
商品コード
1678783

超音波検査の世界市場 (2025年~2033年)

Global Ultrasonography Market - 2025-2033


出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
超音波検査の世界市場 (2025年~2033年)
出版日: 2025年03月11日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の超音波検査市場は、2024年に82億7,000万米ドルに達し、2033年には156億6,000万米ドルに達し、予測期間2025年~2033年のCAGRは6.6%で成長すると予測されています。

超音波画像技術は、音波を利用して体内の画像を作成する技術の1つです。妊娠のモニタリング、心臓疾患の診断、腹部臓器の評価、筋骨格系の損傷の評価など、診断目的に広く利用されています。超音波画像診断としても知られる超音波検査は、非侵襲性、安全性、汎用性が高く、様々な専門分野の医療診断に不可欠なツールとなっています。

世界の超音波検査市場は、非侵襲的で費用対効果の高い診断ツールに対するニーズの高まりと超音波技術の革新により、急速に拡大しています。市場の成長は、ヘルスケア提供の改善、診断精度の向上、世界の医療画像へのアクセス拡大を反映しています。これらの要因が、世界の超音波検査市場拡大の原動力となっています。

市場力学:

促進要因と抑制要因

超音波システムの技術進歩

超音波システムの技術進歩は、世界の超音波検査市場の成長を促進する主要要因の1つです。近年、超音波技術はハードウェアとソフトウェアの両面で大きな進歩を遂げ、医療診断においてより強力で汎用性の高い、使い勝手の良いツールとなっています。こうした技術革新は、さまざまな臨床分野での超音波の応用を拡大し、市場の需要と普及の両方を促進しています。

人工知能(AI)と機械学習の超音波診断システムへの統合は、最も革新的な進歩の1つです。AIアルゴリズムは、画像処理、測定の自動化、異常検出を支援し、診断精度を高め、人為的ミスを減らすことができます。AI駆動システムは、腫瘍、臓器の異常、血栓などの潜在的な健康問題を自動的に検出して強調表示し、より迅速な意思決定を可能にします。

3D/4D超音波画像は、リアルタイムで高解像度の視覚化を可能にし、特に産科のような胎児の開発を見る分野で有用です。特に4D超音波は、動きを捉えることで3D画像にダイナミックな要素を加えます。これらの進歩は、臓器、組織、その他の内部構造の詳細なビューを提供し、診断と患者の転帰を改善します。

さらに、世界の超音波検査市場の成長を牽引する主要企業の革新的な製品もあります。例えば、2025年1月、世界の医療技術企業であるSamsung Medison社は、高度な産婦人科(OB-GYN)アプリケーション向けに特別に設計された新しいAI搭載超音波スキャナーを発表しました。この革新的なシステムは、人工知能(AI)と最先端の画像技術を統合することで、診断精度、ワークフロー効率、患者ケアを向上させる。

また、2023年12月には、サムスンのデジタルX線・超音波部門の米国本社であるボストン・イメージングが、女性の健康と泌尿器科向けに設計されたV6超音波システムを発表しました。この新システムは、2D、3D、カラー画像処理における高度な画像処理機能を提供する一方、予算に優しく、ワークフローの効率化に最適化されています。これらすべての要因が、世界の超音波検査市場に需要をもたらしています。

さらに、低侵襲手術に対する需要の高まりも、超音波検査の世界市場拡大に寄与しています。

熟練した専門家の不足

世界の超音波市場における重要な課題は、熟練した専門家の不足です。超音波診断装置は他の診断ツールに比べて一般的に使い勝手が良いが、それでも専門的なトレーニングや専門知識が必要です。正確な画像を撮影し、それを正しく解釈し、正確な診断を行うためには、超音波検査士、放射線技師、検査技師が不可欠です。

多くの開発途上国や遠隔地では、訓練を受けた超音波専門家がいないため、これらの機器の効果的な使用が制限されています。有資格者がいなければ、誤診や誤った結果が出るリスクが高まり、超音波技術の価値が低下します。先進地域であっても、熟練した専門家への需要が供給を上回ることが多く、ヘルスケア施設では人員不足が生じます。このため、待ち時間が長くなり、サービスへのアクセスが低下し、最終的には、特にサービスが行き届いていない地域における市場の成長が制限されることになります。

目次

第1章 分析手法と分析範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 超音波システムの技術進歩
      • PoC・ポータブルデバイスの需要増加
    • 抑制要因
      • 熟練した専門家の不足
      • 高度な超音波システムの高コスト
    • 機会
      • 低侵襲手術の需要増加
    • 影響分析

第5章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
  • 新たな先駆者と主要企業
  • 最大の売上を誇るブランドを確立したリーダー
  • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析:ベストケース・ベースケース・ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー (KOL)

第6章 製品種類別

  • 2D超音波
  • 3D/4D超音波
  • ドップラー超音波
  • 高密度焦点式超音波(HIFU)
  • その他

第7章 デバイスディスプレイ別

  • カラー超音波
  • 白黒超音波

第8章 ポータビリティ別

  • カート/台車
  • コンパクト
  • ポータブル
  • その他

第9章 用途別

  • 産婦人科
  • 放射線科/一般画像診断
  • 心臓病学
  • 泌尿器科
  • 腫瘍学
  • その他

第10章 エンドユーザー別

  • 病院
  • 画像診断センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第13章 企業プロファイル

  • GE HealthCare
    • 企業概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標(KPI)
      • 製品販売の実績・予測
      • 製品販売量
    • 財務概要
      • 企業の収益
      • 収益シェア:地域別
      • 収益予測
    • 主な動向
      • 企業合併・買収 (M&A)
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Koninklijke Philips N.V.,
  • Siemens Healthcare Private Limited
  • CANON MEDICAL SYSTEMS CORPORATION
  • Mindray Medical India Pvt. Ltd.
  • Samsung Healthcare
  • FUJIFILM Sonosite, Inc.
  • Esaote SPA
  • Hologic(Supersonic Imagine)
  • Konica Minolta, Inc.

第14章 付録

目次
Product Code: MD9271

The global ultrasonography market reached US$ 8.27 billion in 2024 and is expected to reach US$ 15.66 billion by 2033, growing at a CAGR of 6.6 % during the forecast period 2025-2033.

Ultrasound imaging technology is one of the technology which uses sound waves to create images of the inside of the body. It is widely used for diagnostic purposes, including monitoring pregnancies, diagnosing heart conditions, evaluating abdominal organs, and assessing musculoskeletal injuries. Ultrasonography, also known as ultrasound imaging, is non-invasive, safe, and versatile, making it an essential tool in medical diagnostics across a variety of specialties.

The global ultrasonography market is expanding rapidly due to the rising need for non-invasive, cost-effective diagnostic tools and innovations in ultrasound technology. The market's growth reflects improvements in healthcare delivery, enhanced diagnostic accuracy, and expanded access to medical imaging worldwide. These factors have driven the global ultrasonography market expansion.

Market Dynamics: Drivers & Restraints

Technological Advancements in Ultrasound Systems

Technological advancements in ultrasound systems are one of the primary drivers fueling the growth of the global ultrasonography market. Over recent years, ultrasound technology has seen significant improvements in both hardware and software, making it a more powerful, versatile, and user-friendly tool in medical diagnostics. These innovations have expanded the application of ultrasound across various clinical fields, driving both market demand and adoption.

The integration of artificial intelligence (AI) and machine learning into ultrasound systems is one of the most transformative advancements. AI algorithms can assist in image processing, measurement automation, and anomaly detection, enhancing diagnostic accuracy and reducing human error. AI-driven systems can automatically detect and highlight potential health issues, such as tumors, organ abnormalities, or blood clots, enabling faster decision-making.

3D/4D ultrasound imaging allows for real-time, high-resolution visualizations, which is especially useful in fields like obstetrics for viewing fetal development. 4D ultrasound, in particular, adds a dynamic element to 3D imaging by capturing motion. These advancements offer detailed views of organs, tissues, and other internal structures, improving diagnosis and patient outcomes.

Additionally, innovative products from the key players which drive the global ultrasonography market growth. For instance, in January 2025, Samsung Medison, a global medical technology company, introduced a new AI-powered ultrasound scanner specifically designed for advanced obstetrics and gynecology (OB-GYN) applications. This innovative system enhances diagnostic accuracy, workflow efficiency, and patient care by integrating artificial intelligence (AI) and cutting-edge imaging technology.

Also, in December 2023, Boston Imaging, the U.S. headquarters of Samsung's digital radiography and ultrasound division, introduced the V6 ultrasound system, designed for women's health and urology. This new system provides advanced imaging capabilities in 2D, 3D, and color imaging while remaining budget-friendly and optimized for workflow efficiency. All these factors demand the global ultrasonography market.

Moreover, the rising demand for minimally invasive surgical procedures contributes to the global ultrasonography market expansion.

Lack of Skilled Professionals

A significant challenge in the global ultrasound market is the shortage of skilled professionals. While ultrasound machines are generally more user-friendly compared to other diagnostic tools, they still require specialized training and expertise. Sonographers, radiologists, and technologists are essential for capturing accurate images, interpreting them correctly, and ensuring accurate diagnoses.

In many developing countries and remote areas, the lack of trained ultrasound professionals limits the effective use of these devices. Without qualified personnel, the risk of misdiagnosis or incorrect results increases, diminishing the value of ultrasound technology. Even in developed regions, the demand for skilled professionals often surpasses the available supply, creating staffing shortages in healthcare facilities. This leads to longer wait times, reduced access to services, and ultimately restricts the market's growth, particularly in underserved areas.

Segment Analysis

The global ultrasonography market is segmented based on product type, device display, portability, application, end-user, and region.

Portability:

The portable segment is expected to dominate the global ultrasonography market share

Portable ultrasound devices are typically smaller, lighter, and more user-friendly compared to traditional, larger ultrasound machines. This makes them ideal for use in emergency rooms, ICUs, ambulances, rural clinics, and even remote areas where access to traditional ultrasound equipment might be limited.

The portable ultrasound segment is one of the fastest-growing areas within the global ultrasonography market, driven by advancements in technology, increased demand for point-of-care diagnostics, and a focus on enhancing accessibility to medical imaging, particularly in emergency and rural healthcare settings.

Portable ultrasound devices are designed to bring imaging directly to the patient's bedside, enabling point-of-care diagnostics. This allows clinicians to perform ultrasounds immediately during critical situations or emergency care, ensuring quicker diagnoses and faster treatment decisions. For example, cardiac assessments, fetal monitoring, and trauma evaluations can be conducted on-site, improving patient outcomes.

One of the biggest innovations has been the development of portable and handheld ultrasound systems. These compact devices enable clinicians to perform point-of-care diagnostics anywhere, including emergency rooms, intensive care units (ICUs), and even remote areas. Portable ultrasound devices have become particularly valuable in resource-limited settings or for home care.

Additionally, various key players are also one of the key factors that drive this segment growth in the global ultrasonography market. For instance, in December 2024, SuperSonic Imagine, a French-based medical imaging company, introduced PocketVu, a fleet of handheld ultrasound devices designed for diagnostic medical ultrasound imaging. These portable devices offer healthcare professionals a compact, high-performance ultrasound solution that can be used in various clinical settings, such as hospitals, clinics, and emergency care.

Also, in August 2023, GE HealthCare launched a new handheld ultrasound device at the European Society of Cardiology (ESC) Congress, aimed at enhancing point-of-care cardiac imaging. This portable, AI-powered ultrasound system is designed to provide high-quality, real-time imaging, improving diagnostic accuracy and workflow efficiency for cardiologists and emergency care professionals. These factors have solidified the segment's position in the global ultrasonography market.

Geographical Analysis

North America is expected to hold a significant position in the global ultrasonography market share

North America holds a substantial position in the global ultrasonography market and is expected to hold most of the market share. The aging population in North America is a significant factor in the increased demand for diagnostic imaging. Older adults are more prone to conditions like cardiovascular diseases, cancer, arthritis, and musculoskeletal disorders that require regular monitoring and early detection.

This has led to a surge in the use of ultrasound imaging to detect these conditions early and manage them effectively. The increasing prevalence of chronic diseases, such as obesity, diabetes, and heart disease, further boosts demand for ultrasound systems, especially in cardiology and vascular imaging. The rise of artificial intelligence (AI) in ultrasound systems is transforming diagnostic accuracy, speeding up image interpretation, and improving workflow efficiency. AI is used in automating measurements, detecting abnormalities, and enhancing image quality, all of which drive the demand for these systems in North America.

Additionally, in this region, a major number of key players are present, along with an advanced healthcare infrastructure and innovative product launches that would drive this global ultrasonography market growth. For instance, in April 2024, in Chicago, GE HealthCare introduced two new ultrasound systems, Voluson Signature 20 and Voluson Signature 18, designed specifically for women's health imaging. These systems integrate artificial intelligence (AI), advanced diagnostic tools, and an ergonomic design to improve efficiency, accuracy, and patient care.

Also, in November 2023, Siemens Healthineers introduced the ACUSON Maple, a powerful, adaptable, and cost-effective ultrasound system designed to deliver rapid diagnostics across various clinical settings. The system integrates AI-powered features to enhance workflow efficiency, imaging quality, and ease of use, making it accessible to clinicians of all skill levels. Thus, the above factors are consolidating the region's position as a dominant force in the global ultrasonography market.

Asia Pacific is growing at the fastest pace in the global ultrasonography market share

Asia Pacific holds the fastest pace in the global ultrasonography market and is expected to hold most of the market share. The aging population in countries like Japan and South Korea, as well as the increasing burden of chronic diseases across the region, is a significant driver for the ultrasound market. Elderly individuals are at higher risk for conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders, which require frequent diagnostic imaging. This has created a rising demand for ultrasound systems, especially for cardiac imaging, abdominal scans, and fetal health monitoring.

Many APAC countries, particularly India, China, and Southeast Asian nations, have been investing heavily in healthcare infrastructure in recent years. The development of new hospitals, diagnostic centers, and clinics has led to increased demand for medical imaging systems, including ultrasound devices. As healthcare access improves, the use of ultrasonography has become more widespread, particularly in rural and underserved regions.

Healthcare spending in APAC countries has been on the rise, driven by both government investments and private sector growth. This trend has led to an increased demand for advanced diagnostic technologies, including ultrasound systems. The growing demand for point-of-care diagnostics is a major driver in the APAC market. Portable ultrasound systems are being widely adopted in emergency medical services, rural healthcare, and outpatient settings. Compact, wireless, and battery-operated ultrasound devices allow clinicians to perform rapid diagnostics on-site, improving patient care and making ultrasound more accessible.

Additionally, key players in the industry innovative products that would drive this global ultrasonography market growth. For instance, in March 2025, Wipro launched an AI-enabled ultrasound system in India. This innovative ultrasound device is designed to enhance clinical efficiency and diagnostic accuracy by integrating artificial intelligence (AI) and productivity tools. The system will be manufactured locally at Wipro's PLI (Production-Linked Incentive) factory in Bengaluru, marking a significant step toward self-reliance and technological advancement in India's healthcare sector. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global ultrasonography market.

Competitive Landscape

The major global players in the ultrasonography market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, Mindray Medical India Pvt. Ltd., Samsung Healthcare, FUJIFILM Sonosite, Inc., Esaote SPA, Hologic (Supersonic Imagine), and Konica Minolta, Inc., among others.

Key Developments

  • In October 2024, DESKi, a data-driven medtech company, launched the HeartFocus Education app, an AI-powered heart echo (echocardiography) training tool, in partnership with Butterfly Network, Inc. This collaboration aims to enhance medical education by providing a comprehensive and intuitive learning experience for healthcare professionals using portable ultrasound technology.
  • In September 2024, GE HealthCare introduced the Venue Sprint, a tablet-based point-of-care ultrasound (POCUS) system designed to offer fast, accurate imaging in critical care and emergency settings. This portable device enhances clinical decision-making by providing high-quality imaging with an intuitive, AI-powered interface for quick assessments at the bedside.

Why Purchase the Report?

  • Technological & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ultrasonography market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Device Display
  • 3.3. Snippet by Portability
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements in Ultrasound Systems
      • 4.1.1.2. Increasing Demand for Point-of-Care and Portable Devices
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Skilled Professionals
      • 4.1.2.2. High Cost of Advanced Ultrasound Systems
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Demand for Minimally Invasive Surgical Procedures
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
  • 5.2. Emerging Pioneers and Prominent Players
  • 5.3. Established leaders with largest selling Brand
  • 5.4. Market leaders with established Product
  • 5.5. CXO Perspectives
  • 5.6. Latest Developments and Breakthroughs
  • 5.7. Case Studies/Ongoing Research
  • 5.8. Regulatory and Reimbursement Landscape
  • 5.9. North America
  • 5.10. Europe
  • 5.11. Asia Pacific
  • 5.12. Latin America
  • 5.13. Middle East & Africa
  • 5.14. Porter's Five Force Analysis
  • 5.15. Supply Chain Analysis
  • 5.16. Patent Analysis
  • 5.17. SWOT Analysis
  • 5.18. Unmet Needs and Gaps
  • 5.19. Recommended Strategies for Market Entry and Expansion
  • 5.20. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.21. Pricing Analysis and Price Dynamics
  • 5.22. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. 2D Ultrasound*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D/4D Ultrasound
  • 6.4. Doppler Ultrasound
  • 6.5. High-Intensity Focused Ultrasound (HIFU)
  • 6.6. Others

7. By Device Display

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 7.1.2. Market Attractiveness Index, By Device Display
  • 7.2. Color Ultrasound*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Black and White (B/W) Ultrasound

8. By Portability

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 8.1.2. Market Attractiveness Index, By Portability
  • 8.2. Cart/Trolley*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Compact
  • 8.4. Portable
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Obstetrics/ Gynecology *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Radiology/General Imaging
  • 9.4. Cardiology
  • 9.5. Urology
  • 9.6. Oncology
  • 9.7. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Mexico
      • 11.4.8.2. Brazil
      • 11.4.8.3. Argentina
      • 11.4.8.4. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Display
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE HealthCare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals, etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Koninklijke Philips N.V.,
  • 13.3. Siemens Healthcare Private Limited
  • 13.4. CANON MEDICAL SYSTEMS CORPORATION
  • 13.5. Mindray Medical India Pvt. Ltd.
  • 13.6. Samsung Healthcare
  • 13.7. FUJIFILM Sonosite, Inc.
  • 13.8. Esaote SPA
  • 13.9. Hologic (Supersonic Imagine)
  • 13.10. Konica Minolta, Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us